🇺🇸 FDA
Patent

US 8211876

Compositions for treatment of inflammatory diseases

granted A61KA61K31/13A61K31/198

Quick answer

US patent 8211876 (Compositions for treatment of inflammatory diseases) held by The Regents of the University of Oklahoma expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Oklahoma
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/13, A61K31/198, A61K31/355, A61K31/375